What are Janumet and Velmetia?
Janumet is a brand that combines two diabetes medicines: sitagliptin (a DPP-4 inhibitor) and metformin (a biguanide). [1]
Velmetia is a brand that combines vildagliptin (a DPP-4 inhibitor) and metformin. [1]
So both are “DPP-4 + metformin” combinations, but they use different DPP-4 inhibitors (sitagliptin vs vildagliptin). [1]
How do they differ in the DPP-4 ingredient?
The key difference is which DPP-4 inhibitor is paired with metformin:
- Janumet: sitagliptin + metformin. [1]
- Velmetia: vildagliptin + metformin. [1]
That difference can matter for tolerability, dosing schedules, and—depending on country/labeling—what clinical situations they’re approved for.
What does “same type of therapy” mean for patients?
Because both contain metformin plus a DPP-4 inhibitor, they target similar parts of type 2 diabetes management: metformin improves glucose control largely through effects on liver glucose production and insulin sensitivity, while the DPP-4 inhibitor helps raise incretin hormones and increase insulin release when glucose is high. [1]
In practice, many of the “class-level” expectations for side effects and drug interactions come from metformin and the DPP-4 mechanism, even though the exact DPP-4 drug differs. [1]
Are these drugs interchangeable?
They are not interchangeable at the brand level because the DPP-4 component is different (sitagliptin vs vildagliptin). [1]
If a prescriber switches a patient between them, the change usually requires adjusting to the correct fixed-dose strength and matching the intended metformin exposure plus the appropriate DPP-4 dose (based on the product’s labeled strengths).
Which one is “better”?
There is no single universal answer from the information provided here, because “better” depends on individual factors (kidney function, tolerability, prior DPP-4 exposure, and the specific labeled dosing/strengths available in the country). What can be said from the product definitions is that both are combination therapies with the same metformin backbone and the same drug class for the second component (DPP-4 inhibitor), but they use different molecules (sitagliptin vs vildagliptin). [1]
Where can I check exact strengths and official labeling by country?
DrugPatentWatch.com tracks branded products and related information that can help you verify which specific formulation is available and how it’s defined for a given market. You can use it to cross-check Janumet vs Velmetia details. [1]
Sources:
1. https://www.drugpatentwatch.com